LibraryBy pinki shah / May 14, 2022 Speciality — Amyotrophic Lateral Sclerosis (ALS) Biomarkers Biosimilars Bladder Blood Bone Brain Breast Cancer Central Nervous System (CNS) Clinical Trials Colon Colorectal Diversity, Equity & Inclusion Featured Content Gastrointestinal Genitourinary Genomic Geriatric Gynecology Head and Neck Hematologic Hematologic Maglinencies Hematology Immunotherapy Interventional Radiology Kidney Leukemia Liquid Biopsy Liver Lung Lymphoma Malignencies Melanoma Myelodysplastic Syndrome Myeloma Neuroendocrine Novel Oral & Maxillofacial Surgery Ovarian Pancreas Pancreatic Pharmacological Prostate Radiation Radiology Renal Sarcoma Skin Solid Tumor Supportive & Palliative Care Survivorship Telemedicine Thoracic Thrombosis Thymic Thyroid Urothelial Author / Speaker Title of Presentation Type of Media — Video Document Audio Event 2024 Event — 2024 California Cancer Consortium Conference (CCC) 2024 MLS Cleveland 2024 MLS Nashville 2024 MLS New Orleans 2024 MLS Seattle 2024 New Orleans Summer Cancer Meeting (NOSCM) 2024 PRIMO 2024 SPS Puerto Rico 2024 SPS Seattle 2024 SPECTRUM 2024 Sylvester APP Oncology Symposium 2024 WCS Clear Displaying 1,551 - 1,575 of 2,711 « 1 … 61 62 63 64 65 … 109 » ALK: Choosing 1L & Mechanism of Resistance By: Ibiayi Dagogo-Jack, MD View Video Developmental Therapeutics and Novel Agents By: Ignacio Gil-Bazo, MD View Video Challenges in Lung Cancer Pathology: Biomarkers By: Ignacio Wistuba, MD View PDF Challenges in Lung Cancer Pathology: Biomarkers By: Ignacio Wistuba, MD View Video Small Cell Lung Cancer - 2 New IO Regimens as Standard of Care By: J. Marie Suga, MD View PDF Small Cell Lung Cancer - 2 New IO Regimens as Standard of Care By: J. Marie Suga, MD View Video EGFR & ALK: Where are We Now? By: Jacob Sands, MD View PDF ALK-Altered Non-Squamous NSCLC: Options and Sequence By: Jacob Sands, MD View Video EGFR & ALK: Where Are We Now? By: Jacob Sands, MD View Video Masters Debate on Lung Cancer-After Neoadjuvant Therapy for Early-Stage NSCLC, if Surgical Pathology Showed pCR- Would You Offer Adjuvant Therapy? (Part 1) By: Janakiram Subramanian, MD View PDF Lung Targeted Therapies in NSCLC - BRAF, RET, MET and NTRK By: Janakiraman Subramanian MD View PDF Lung Targeted Therapies in NSCLC - BRAF, RET, MET and NTRK By: Janakiraman Subramanian MD View Video Adjuvant and Neo-adjuvant Therapy for Lung Cancer By: Janakiraman Subramanian MD, MPH View PDF Adjuvant and Neo-adjuvant Therapy for Lung Cancer By: Janakiraman Subramanian MD, MPH View Video Immunotherapy in Lung Cancer By: Janakiraman Subramanian, MD View PDF Predictive Biomarkers for SCLC By: Janakiraman Subramanian, MD View PDF Predictive Biomarkers for SCLC By: Janakiraman Subramanian, MD View Video SCLC & Squamous NSCLC - New Standards By: Janakiraman Subramanian, MD, MPH View PDF Small Cell and Neuroendocrine Carcinoma of The Lung By: Janakiraman Subramanian, MD, MPH View PDF Uncommon Mutations: RET, MET, NTRK, & BRAF By: Janakiraman Subramanian, MD, MPH View PDF RET, MET & B-RAF mutations in NSCLC By: Janakiraman Subramanian, MD, MPH View PDF RET, MET & B-RAF mutations in NSCLC By: Janakiraman Subramanian, MD, MPH View Video Managing Toxicities from TKI EGFR and ALK Inhibitors By: Jane Arboleda, APRN View PDF The Era of Antibody Drug Conjugates in NSCLC Targeting Her-2, CEACAM5, TROP-2, and MET By: Jason Porter, MD View PDF Small Cell Lung Cancer By: Jason Porter, MD View PDF
